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Effect of yoga on FEV1, 6-minute walk distance  
(6-MWD) and quality of life in patients with COPD group B
Abstract
Introduction:	Yoga	is	used	in	the	treatment	of	various	diseases,	including	chronic	obstructive	pulmonary	disease.	However,	no	
studies	have	assessed	the	effect	of	yoga	on	COPD	patients	in	Indonesia.	The	difference	between	this	study	and	similar	studies	
completed	in	other	countries	lies	in	the	type	of	yoga	exercises	completed,	the	method	in	which	they	were	completed,	and	in	
certain,	unique	demographic	characteristics.	This	study	aims	to	analyze	the	effect	of	yoga	on	FEV1,	6-minute	walk	distance,	and	
quality	of	life	in	patients	with	COPD	group	B	in	Indonesia.
Material and methods:	This	article	reflects	research	done	in	the	form	of	an	experimental	study	using	a randomized	controlled	
trial	with	pre	and	post-test	control	group	design.	The	samples	were	divided	into	2	groups:	the	treatment	group	(yoga	practice	for	
1	hour,	2	times	a week	for	12	weeks)	and	the	control	group	(untreated	with	yoga,	given	lung	rehabilitation	brochure).	Assessment	
of	the	effect	of	yoga	exercises	on	lung	function	parameters	(FEV1),	6-minute	walk	distance	and	quality	of	life	were	used	using	
SGRQ	questionnaires	in	COPD	group	B.
Results:	33	COPD	patients	fulfilled	the	inclusion	criteria.	30	patients	completed	the	study.	Pre	and	post	yoga	results	were	evalu-
ated	in	the	treatment	group	versus	the	control	group	and	then	further	assessed	using	statistical	tests.	There	was	a significant	in-
crease	in	FEV1,	6-MWD	and	quality	of	life	using	a SGRQ	questionnaire	after	12	weeks	of	yoga	(p	<	0.05)	as	well	as	a a significant	
change	in	FEV1,	6-MWD	and	quality	of	life	in	the	treatment	group	(p	<	0.05)	when	compared	with	the	control	group	(p	>	0.05).
Conclusions:	Yoga	affects	FEV1,	6-MWD,	and	quality	of	life	in	patients	with	Group	B	COPD.
Key words:	yoga,	COPD,	FEV1,	6-MWD,	quality	of	life,	SGRQ
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Introduction
Chronic obstructive pulmonary disease 
(COPD) is one of the non-communicable dise-
ases that is becoming an important public health 
issue in Indonesia. The morbidity and mortality 
of COPD patients is associated with periodic ex-
acerbations or worsening of symptoms [1, 2]. As 
the frequency of exacerbations increases, damage 
to the lungs proportionately rises in severity. 
This is ultimately followed by a decrease in lung 
function [3]. Problems frequently experienced 
by COPD patients, especially in stages II and III, 
include exercise de-conditioning, muscle wasting, 
weight loss, depression, and isolation. Therefore, 
comprehensive management of COPD symptoms 
in patients suffering from the disease is necessary 
to improve their quality of life [3].
Outside of pharmacological therapy, some 
COPD patients are managed non-pharmacologi-
cally (i.e. by smoking cessation and pulmonary 
rehabilitation) [3, 4]. The main purpose of pul-
monary rehabilitation is to reduce complaints, 
improve physical ability to perform daily activ-
ities, improve emotions, and improve quality of 
life [3, 5].
Research has shown that exercises such as 
upper body workouts, Tai Chi, and yoga can im-
prove COPD patients’ quality of life [6]. Yoga has 
been included as a recommended exercise com-
ponent for pulmonary rehabilitation programs. 
In addition to the treatment of physical therapy 
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in industrial rehabilitation programs, it has been 
proven to improve the coordination of mind 
and body. Yoga is called a “low impact” exercise 
that can be adapted to the needs and abilities of 
practitioners so that it is suitable for anyone. This 
includes COPD patients through activities such as 
asana (yoga posture) and pranayama (breathing 
technique). Short-term studies on yoga practice 
have reported an increase in pulmonary function 
parameters, diffusion capacity, improvement in 
the quality of life, and a  reduction in asthma- 
-induced stress. Yoga has also been proven to be an 
effective tool for coal miners with COPD [6]. This 
study serves to further research the impact and 
confirm the beneficial role of yoga in COPD based 
on the information that has been described above.
Material and methods
Study design
This article reflects research done in the form 
of an experimental study using a  randomized 
controlled trial with pre and post-test control 
group design . The initial step was made one week 
before the start of the intervention by performing 
CAT score and mMRC score assessments to ensure 
that COPD group B was included in this study. 
Then, spirometry assessments were conducted 
using the Koko Legend Spirometer (606055 9.A), 
and 6-MWD was performed. Every result was re-
calculated according to GLI-2012 and add z-score 
assessment to the analysis [7]. The follow-up 
steps were carried out one week after completion 
of the intervention, which lasted 12 weeks. Yoga 
classes were undertaken in one setting which was 
determined by the researcher. Classes were led 
by a certified yoga instructor.
Statistical analysis
The data normality test was done using the 
Shapiro-Wilk test. Analysis of variance before 
and after treatment was carried out using a paired 
T-test or Wilcoxon Signed Ranks Test. Analysis of 
variance between yoga groups and control groups 
was made using the independent sample T-test or 
Mann-Whitney test.
Participants
Participants were recruited from clinics and 
pulmonary rehabilitation centers, or by physi-
cian referral. Inclusion criteria comprised men 
over the age of 40, patients with stable COPD 
category B, patients that were willing to follow 
the research criteria properly and patients who 
agreed to informed consent. Exclusion criteria 
included patients suffering from COPD which was 
accompanied by other diseases (i.e. neoplasm, 
congestive heart failure and/or asthma). Dropout 
criteria included subjects who refused to partici-
pate in the research, did not undergo the research 
protocol, and/or experienced exacerbations more 
than one time.
Randomization
All participants agreed to be randomized. 
Stratified randomization was done using baseline 
measures of spirometry to ensure participant bal-
ance in disease severity. They were randomized 
according to time of attendance. Odd dates were 
included in the yoga group, and even dates were 
included in the control group. Participants in both 
groups continued to receive normal care, and 
those in the yoga group continued to attend the 
program. All participants were asked to refrain 
from learning or practicing anything other than 
what is taught during yoga interventions. Also, 
participants in the yoga intervention group signed 
a confidentiality agreement not to discuss class 
content with fellow participants in the control 
group.
Intervention
Yoga interventions consisted of yoga classes 
that lasted 60 minutes twice a week, every week 
for 12 weeks. Yoga instructors must have had 
formal training. Due to the need for supplemental 
oxygen in order to maximize the effectiveness for 
persons with COPD, the class time was limited 
to 60 minutes. The program minimized the tradi-
tional focus on breathing during the beginning of 
yoga exercises to address issues related to persons 
with COPD. The management of non-threatening 
symptoms that focused on raising awareness of 
the dangers of dyspnea was included. Ujjayi, 
Kaphalabati, and Sitkari breathing were includ-
ed. Further, a spiritual focus was introduced to 
augment a feeling of comfort during meditation. 
Savasana was chosen as the meditative move-
ment exercise. This was based on the expertise 
of the teacher leading the intervention.
Results
Characteristics of research subjects 
Table 1 shows the characteristics of these 
research subjects. The number of research sub-
jects was 33 people, all of them being males. 
Subjects excluded from the research consisted 
of 3 people: 2 people from the treatment group, 
and 1 person from the control group. The num-
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Table 1. Characteristics of research subjects
Characteristics Groups P-value
Treatment (yoga) Control
Age mean (SD) 64.40	(10.453) 65.33	(8.121) 0.787
<	51	years 1	(6.7%) 0	(0.0%)
51–60	years 4	(26.7%) 5	(33.3%)
61–70	years 5	(33.3%) 5	(33.3%)
71–80	years 4	(26.7%) 5	(33.3%)
≥	81	years 1	(6.7%) 0	(0.0%)
IMT mean (SD) 23.59	(5.366) 20.42	(3.770) 0.072
<	18.5	(less) 1	(6.7%) 4	(26.7%)
18.5–24.9	(normal) 3	(20.0%) 10	(66.7%)
25–29.9	(excess) 9	(60.0%) 1	(6.7%)
≥	30	(obesity) 2	(13.3%) 0	(0.0%)
Comorbid 
Non	comorbid 11	(73.3%) 11	(73.3%) 0.557
Hypertension 1	(6.7%) 1	(6.7%)
DM 3	(20.0%) 1	(6.7%)
Coronary	heart	disease 0	(0.0%) 2	(13.3%)
Smoking duration mean (SD) 33.21	(8.781) 25.62	(12.984) 0.085
<	20	years 0	(0.0%) 2	(15.4%)
20–39	years 10	(71.4%) 8	(61.5%)
≥	40	years 4	(28.6%) 3	(23.1%)
Number	of	cigarettes	per	day	(median/range) 24	(12	until	48) 12	(12	until	30) 0.144
<	20	 5	(35.7%) 8	(61.5%)
20–29	 6	(42.9%) 4	(30.8%)
>	30	 3	(21.4%) 1	(7.7%)
Brinkman Index 
0–199	(light) 0	(0.0%) 2	(15.4%) 0.104
200–599	(medium) 6	(42.9%) 8	(61.51%)
≥	600	(high) 8	(57.1%) 3	(23.1%)
Obstruction degree
GOLD	1 1	(6.7%) 1	(6.7%) 0.895
GOLD	2 5	(33.3%) 3	(20.0%)
GOLD	3 4	(26.7%) 5	(33.3%)
GOLD	4 5	(33.3%) 6	(40.0%)
ber of subjects that took part in the study until 
its completion was 30 people. Based on the 
degree of COPD, in the treatment group there 
were 5 people in category GOLD 2 and 5 people 
in category GOLD 4 (33.3%). Meanwhile, in the 
control group, there were 6 people (40%) in the 
GOLD 4 obstruction degree.
The results of the normal distribution test 
using the Shapiro-Wilk test showed that the data 
on differences in 6-MWD in the yoga and control 
groups and the impact data of the yoga group were 
not normally distributed (p < 0.05). Therefore, 
the paired T-test was used to find out differences 
in observations before and after treatment was 
given in each group, except for the difference in 
6-MWD using the Wilcoxon Signed Rank Test. 
Meanwhile, the T-test of 2 free samples was used 
to observe differences in findings between yoga 
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Table 2.  Results of the T-test of FEV1 (L) and  FEV1 (%) before and after treatment given in each group and T-tests among 
groups
    Mean (standard deviation) P-value
Yoga group Control group T-test of 2 free samples
n = 15 n = 15
FEV1	(L) Before	 1.025	(0.507) 0.941	(0.488) 0.647
After	 1.402	(0.629) 1.017	(0.534) 0.082
Difference	 0.377	(0.364) 0.077	(0.273) 0.016
P-value
0.001 0.295
 
Paired	T-test
FEV1	(%) Before 43.53	(20.625) 40.87	(22.309) 0.736
After 58.93	(22.799) 44.60	(22.344) 0.093
Difference 15.40	(15.371) 3.733	(10.964) 0.024
P-value
0.002 0.208
 
Paired	T-test
FEV1, 	
Z-score
Before –3.558	±	1.089 -3.409	±	0.986 0.697
After –2.613	±	1.302 -3.162	±	1.191 0.239
Different 0.945	±	0.786 0.247	±	0.617 0.011
P-value
0.001 0.144
Paired	T-test
and control groups except for the difference in the 
impact after treatment, which was done using the 
Mann-Whitney test.
FEV1 change
FEV1 assessment was carried out in the two 
groups. Mean FEV1 in the treatment group before 
yoga was 1.025 L (0.507), while in the control 
group was 0.941 L (0.488). FEV1 re-assessment 
was carried out after 12 weeks. In the treatment 
group there was an increase to 1.402 L (0.629) 
(p = 0.001) while in the control group there was 
an increase to 1.017 L (0.534) (p = 0.295). 
Table 2 shows the results of the paired T-test 
of FEV1 (L) and FEV1 (%) before and after treatment 
was given in each group and before T-test among 
these groups. There were significant differences in 
FEV1 (L) before and after treatment in the yoga group 
(p < 0.05), whereas no significant differences were 
noted in the control group (p > 0.05). The results 
of the T-test of 2 free samples between the yoga 
and control groups indicated that there were no 
significant differences in FEV1 (L) both before and 
after treatment (p > 0.05), but there were significant 
differences in the value of FEV1 (L) (p < 0.05).
As can be seen in Table 2, the mean FEV1 
(% prediction) in the treatment group before yoga 
was 43.53% (20.625). In the control group, it was 
40.87% (22.309). FEV1 re-assessment was carried 
out after 12 weeks. In the treatment group there was 
an increase of 58.93% (22.799) (p = 0.002), and in 
the control group there was an increase of 44.60% 
(22.344) (p = 0.208). The results of the paired T-test 
showed significant differences in FEV1 (%) before 
and after treatment in the yoga group (p < 0.05), 
whereas there were no significant differences in the 
control group (p > 0.05). The results of the T-test 
of 2 free samples between the yoga and control 
groups indicated that there were no significant dif-
ferences in FEV1 (%) both before and after treatment 
(p > 0.05), but there were significant differences 
in the value of FEV1 (%) (p < 0.05).
6-MWD change
As can be seen in Table 3, there was an in-
crease in mean 6-MWD after yoga in the treatment 
group. The Wilcoxon Signed Rank Test results 
in the treatment group showed no significant 
difference in 6-MWD value before and after yoga 
with a p-value of 0.001. It can be concluded that 
patients with COPD treated with yoga have a sig-
nificantly increased 6-MWD value, whereas in the 
control group there was a decrease in the mean 
of 6-MWD after 12 weeks. The Wilcoxon Signed 
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Table 4. Result of symptoms, activity, impact and SGRQ total before and after treatment given in each group 
    Mean (standard deviation) P-value
Yoga group Control group T-test of 2 free  
samples
n = 15 n = 15
Symptoms Before 54.26	(16.257) 50.63	(21.031) 0.601
After	 23.26	(14.941) 48.91	(26.145) 0.003
Difference -30.99	(21.398) -1.73	(17.155) <	0.0001
P-value
<	0.0001 0.703
 
Paired	T-test
Activity Before 56.08	(21.860) 56.27	(23.602) 0.981
After	 28.62	(24.037) 54.48	(21.843) 0.005
Difference -27.46	(21.481) -1.80	(12.999) 0.001
P-value
<	0,0001 0.601
 
Paired	T-test
Impact Before 37.20	(18.784) 48.29	(23.259) 0.162
After	 13.21	(12.787) 43.85	(22.605)  
Difference -23.99	(14.533) -4.44	(14.851) 0.001
P-value
<	0.0001 0.266
 
Paired	T-test
Total	score Before 45.76	(16.318) 51.10	(21.135) 0.445
After	 19.55	(14.305) 47.93	(20.405) <	0.0001
Difference -26.20	(14.514) -3.17	(12.884) <	0.0001
P-value
<	0.0001 0.357
 
Paired	T-test
Median (IQR) Mann-Whitney test
Impact After 8.14	(17.48) 45.63	(38.07) 0.001
The effect of yoga that was demonstrated in 
this research study relates to the deep breathing 
technique (Pranayama) and meditation, leading 
to a  respiratory rate reduction. This has many 
beneficial effects: it enables the modulation of 
airway reactivity, improves breathing sensation 
through regulating breathing pattern, reduces 
oxygen consumption, reduces the incidence of 
hypoxia and hypercapnia, improves blood oxy-
genation without increasing ventilation, improves 
respiratory resistance, improves muscle strength 
and modulates autonomic function by decreasing 
heart rate at rest and sympathetic activity [3, 10].
The result of this research is in line with the 
results obtained by Katiyar [9] and Donesky [10] 
which showed that there was a  significant in-
crease in 6-MWD in a COPD group which took 
part in yoga exercises. Ranjita [12] also obtained 
a similar result showing a significant increase in 
COPD patients symptoms after completing yoga 
exercises over a 12 week period. The increase 
in 6-MWD is due to the effect of yoga on the 
musculoskeletal and cardiorespiratory systems, 
improving cardiovascular efficiency and homeo-
static control of the body. The effect on muscle 
during continuous yoga stretch posture helps to 
increase oxidative capacity and skeletal muscle 
strength, flexibility, endurance, coordination, 
power, static and dynamic balance. It also helps 
to reduce glycogen utilization which improves 
physical performance, walking speed, and step 
length. Relaxation techniques have been found 
to increase cardiopulmonary resistance through 
body and breathing control, which manifests 
clinically as lung capacity increase, oxygen 
delivery increase and breathing rate reduction. 
Therefore, overall, it can increase exercise capac-
ity at 6-MWD [12].
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Quality of life is assessed by the SGRQ ques-
tionnaire which consists of symptoms, activity, 
impact, and total score of each group. The as-
sessment of the quality of life increases when the 
SGRQ value is decreased. The British Thoracic 
Society (BTS) recommends using SGRQ as it is 
more sensitive in assessing clinical change. The 
SGRQ questionnaire can also be used to detect 
the response to medical treatment or non-medical 
treatment, as is the case in a lung rehabilitation 
program. Clinical change is considered to be sig-
nificant if the SGRQ value decreases by 4% [4].
The SGRQ change in the yoga group is greater 
than in the control group in each component of 
the SGRQ questionnaire. The test result showed 
a significant difference in the change of SGRQ 
questionnaire value (symptom, activity, impact, 
total score) with a p-value of < 0.05. It can be 
concluded that patients with COPD treated with 
yoga have a significantly bigger decrease in SGRQ 
questionnaire values in some components (symp-
tom, activity, impact and total score) compared to 
patients with COPD untreated with yoga.
This research is in line with previous com-
pleted studies. In the investigation completed 
by Fulambarker [13] and Katiyar [9], there was 
a significant change in the quality of life through 
the assessment of the SGRQ questionnaire in 
the group given yoga treatment for 12 weeks (24 
meetings). There was a decrease in the mean value 
of SGRQ in the treatment group for 12 weeks in 
terms of symptoms, activity, impact, and total 
score. It means that there is an improvement in 
the quality of life in the treatment group. Lacasse 
et al., as part of their research via a meta-analysis, 
concluded that pulmonary rehabilitation will re-
duce shortness of breath symptoms and improve 
COPD patient’s ability to be active, which will 
improve functional capacity and quality of life 
[14]. Berry et al. explained that pulmonary reha-
bilitation would increase the maximum oxygen 
consumption and maximum working capacity, 
thereby increasing the functional capacity and 
quality of life [15].
This study also consistent with Kulpati et al. 
Patients who received yoga training were seen to 
have the best maintenance of function, reduction 
in the respiratory rate (p < 0.001) and heart rate 
(p < 0.01) compared with a group who received 
conventional therapy, while a group who received 
breathing exercise that only intermediate in their 
response, probably indicated the efficacy of yo-
gasanas [16].
Yoga exercise will improve the functioning 
of bodily systems, namely in the nervous system 
and in all organs of the body. It also affects the 
psychological and spiritual aspects. Yoga exer-
cise is a process of integrating aspects of oneself, 
including physical, psychological, and spiritual 
aspects. The optimal integration process enables 
a person to achieve the quality of life that they 
expect. A healthy body condition is indicated 
by the enhancement of psychological well-being 
(positive psychological conditions such as mood 
and happiness improve, whilst at the same time 
decreasing negative psychological symptoms 
including stress, anxiety, and depression). Prac-
ticing yoga also affects spiritual aspects. It allows 
for greater self-respect, respect of others and the 
surrounding environment, allows one to be closer 
to God and to have a meaningful life [17].
This study is consistent with Villien F’s re-
search [18], which concluded that changes in 
breathing patterns could be used as a measure 
of participating in meditational interventions. 
However, it is possible that emotions can me-
diate the relationship between respiratory rate 
and level of mindfulness. Respiratory patterns 
have been demonstrated to be stable over time 
and fluctuate in a  consistent manner during 
changes in respiratory demand, such as exer-
cise. Despite this stability, respiration patterns 
have been shown to change at rest in response 
to meditational practices in persons without pul-
monary disease. After attending a meditational 
intervention which focused on Ujjayi breathing, 
it was found that healthy persons demonstrated 
a decrease in respiratory rate and an increase in 
expiratory time [18].
Conclusions
Yoga has beneficial effects in COPD Group B. 
FEV1, 6-MWD, and the quality of life increase after 
yoga exercise. Therefore, yoga can be used as an 
option for pulmonary rehabilitation in patients 
with COPD category B. The pulmonary rehabili-
tation program should be given continuously in 
patients with COPD. However, pulmonary reha-
bilitation needs to be performed together with the 
instructor within a set exercise schedule in order 
to achieve the proper movements that correspond 
to the set procedures.
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